These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 886069)

  • 1. [Kinetic patterns of changes in the number of peripheral blood leukocytes in lung cancer patients after treatment with cyclophosphane combined with cystaphos].
    Disvetova VV; Levitin EI; Trakhtenberg AKh; Batinov IN
    Izv Akad Nauk SSSR Biol; 1977; (3):351-6. PubMed ID: 886069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ways of reducing the toxicity of chemotherapy of cancer of the ovaries].
    Shuvaeva NI; Novikova EG; Vedernikova NV; Antoshechkina ET
    Sov Med; 1986; (5):24-8. PubMed ID: 3088736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of lung neoplasms with massive single doses of cyclophosphane in combination with the protector cystaphos].
    Batinov IN; Trakhtenberg AK; Trubnikova EN; Sukhin GM
    Vopr Onkol; 1971 Dec; 17(12):83-4. PubMed ID: 5144166
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of cystaphos on the occurrence of hemorrhagic diathesis in the acute radiation syndrome].
    Milosević Z; Horsić E; Selak I; Kljajić R; Marković Z
    Vojnosanit Pregl; 1984; 41(5):320-5. PubMed ID: 6516239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of cystaphos in protecting animals from gamma irradiation].
    Milovanović A; Cosić M
    Vojnosanit Pregl; 1983; 40(5):325-8. PubMed ID: 6649508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicity and radioprotective effect of certain sulfur-containing protectors when administered orally in combination].
    Suroegin EB
    Radiobiologiia; 1980; 20(5):746-9. PubMed ID: 6255509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytogenetic activity of radioprotectors in a culture of human lymphocytes. V].
    Arutiunian RM; Danielian EA; Oganian VK; Sarkisian TF
    Tsitol Genet; 1978; 12(3):228-31. PubMed ID: 98875
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of large single doses of cyclophosphane (endoxan)].
    Garin AM
    Vopr Onkol; 1970; 16(11):43-8. PubMed ID: 4929048
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the administration of massive doses of endoxan in pulmonary neoplasms].
    Górecki R; Brodziak R; Gondorowicz K; Stanek S
    Gruzlica; 1969 Mar; 37(3):251-4. PubMed ID: 4182112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with ambulatory intermittent cytostatic treatment of bronchial cancer].
    Macholda F; Bohut V; Votava V; Pavlova P; Mericka O; Sajnerova B
    Bronches; 1971; 21(2):197-201. PubMed ID: 4108245
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclophosphamide, adriamycin and vincristine (CAV) in the treatment of small cell lung cancer].
    Kawahara M; Tsuruta M; Furuse K; Arai R; Kodama N; Yamamoto M; Kubota K; Nakai R; Ogawara M
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):457-62. PubMed ID: 2831819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased apoptosis of peripheral blood leukocytes correlates with leukopenia after high-dose chemotherapy].
    Chukhlovin AB
    Vopr Onkol; 1999; 45(4):384-6. PubMed ID: 10532096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of cystaphos on the state of motor function of the gastrointestinal tract of monkeys].
    Znamenskiĭ VV; Terekhov AV; Simovonian VG; Zeĭmunian KA
    Med Radiol (Mosk); 1975 Oct; 20(10):65-7. PubMed ID: 813082
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum.
    Kligerman MM; Blumberg AL; Glick JH; Nelson DF; Glover D; Yuhas JM; Amols HI; Goodman RL
    Cancer Clin Trials; 1981; 4(4):469-74. PubMed ID: 6274534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the radioprotector WR 2721 on the response of metastatic Lewis lung carcinoma colonies to alkylating agents.
    Wist EA
    Acta Radiol Oncol; 1985; 24(3):259-62. PubMed ID: 2994377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M; Baker LH; Opipari M; Al-Sarraf M
    Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Restorative effect of muroctasin, MDP-Lys (L 18), on leukopenia caused by anticancer chemotherapy in lung cancer--comparative study by envelope method].
    Takada M; Fukuoka M; Takifuji N; Sakai N; Ryu S; Masuda N; Matsui K; Negoro S; Kusunoki Y; Tsubura E
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3095-101. PubMed ID: 3142367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of two combination chemotherapies for the treatment of small cell carcinoma of the lung.
    Kutsuzawa T; Hayashi Y; Kurata T; Kobayashi R; Kondo T; Sonoda Y; Takasaki Y; Shioya S; Yamauchi T; Tamaya S
    Tokai J Exp Clin Med; 1984 Dec; 9(5-6):363-9. PubMed ID: 6100629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.